• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Alpha Tau Medical Ltd. - Ordinary Shares (NQ: DRTS )

    2.290 UNCHANGED
    Streaming Delayed Price Updated: 2:38 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Alpha Tau Medical Ltd. - Ordinary Shares

    < Previous 1 2 3 Next >
    Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Alpha Tau Treats First Patient with Recurrent Lung Cancer
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
    -Trial to focus on particularly vulnerable subset of patients, following strong clinician interest in use of the Alpha DaRT in this patient population - 
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Expert Ratings for Alpha Tau Medical
    Via Benzinga
    Analyst Ratings for Alpha Tau Medical
    Via Benzinga
    DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q2 2024
    DRTS stock results show that Alpha Tau Medical beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q1 2024
    DRTS stock results show that Alpha Tau Medical beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Recap: Alpha Tau Medical Q1 Earnings
    Via Benzinga
    DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q4 2023
    DRTS stock results show that Alpha Tau Medical beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
    Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    We're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Sidoti Events, LLC's Virtual June Small-Cap Conference
    Via ACCESSWIRE
    Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University
    -First patient treated in the feasibility and safety study of intratumoral diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of new and recurrent squamous cell carcinoma of the... 
    From Alpha Tau Medical Ltd.
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.